Novo Nordisk A/S shares are on track for their worst week this year, after a Super Bowl advertisement touting copycat ...
A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback